UK markets close in 38 minutes

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.80+0.55 (+4.89%)
As of 10:52AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,780
8,780
12,405
0
0
Operating expenses
Research development
82,231
82,231
77,837
54,168
32,197
Selling general and administrative
41,322
41,322
38,924
31,897
20,847
Total operating expenses
123,553
123,553
116,761
86,065
53,044
Operating income or loss
-114,773
-114,773
-104,356
-86,065
-53,044
Total other income/expenses net
166
166
167
140
101
Income before tax
-104,699
-104,699
-101,067
-85,805
-52,243
Income from continuing operations
-104,699
-104,699
-101,067
-85,805
-52,243
Net income
-104,699
-104,699
-101,067
-85,805
-52,243
Net income available to common shareholders
-104,699
-104,699
-101,067
-85,805
-52,243
Basic EPS
-2.60
-2.38
-2.60
-2.34
-1.56
Diluted EPS
-2.60
-2.38
-2.60
-2.34
-1.56
Basic average shares
38,897
43,995
38,897
36,739
33,488
Diluted average shares
38,897
43,995
38,897
36,739
33,488